Literature DB >> 11704846

Function of RARalpha during the maturation of neutrophils.

P Kastner1, S Chan.   

Abstract

The retinoic acid receptor alpha gene is the target of chromosomal rearrangements in all cases of acute promyelocytic leukemia (APL). This recurrent involvement of RARalpha in the pathogenesis of APL is likely to reflect an important role played by this receptor during the differentiation of immature myeloid cells to neutrophils. RARalpha is a negative regulator of promyelocyte differentiation when not complexed with RA, and stimulates this differentiation when bound to RA. Since RARs are dispensable for the generation of mature neutrophils, their role thus appears to be to modulatory, rather than obligatory, for the control of neutrophil differentiation. In vitro, retinoic acid is also a potent inducer of neutrophil cell fate, suggesting that it might play a role in the commitment of pluripotent hematopoietic progenitors to the neutrophil lineage. Thus, the APL translocations target an important regulator of myeloid cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704846     DOI: 10.1038/sj.onc.1204757

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  No evidence for PML-RARa bcr1 fusion gene in colorectal cancer.

Authors:  Marta Herreros-Villanueva
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.

Authors:  Hitoshi Yoshida; Hitoshi Ichikawa; Yusuke Tagata; Takuo Katsumoto; Kazunori Ohnishi; Yukihiro Akao; Tomoki Naoe; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

Review 3.  Minireview: Nuclear receptors, hematopoiesis, and stem cells.

Authors:  John P Chute; Joel R Ross; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-24

Review 4.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

5.  Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.

Authors:  Lei Wang; Murat O Arcasoy; Stephanie S Watowich; Bernard G Forget
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

6.  Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.

Authors:  John S Welch; Jeffery M Klco; Nobish Varghese; Rakesh Nagarajan; Timothy J Ley
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

7.  Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.

Authors:  Garrett G Muramoto; J Lauren Russell; Rachid Safi; Alice B Salter; Heather A Himburg; Pamela Daher; Sarah K Meadows; Phuong Doan; Robert W Storms; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

8.  Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells.

Authors:  Rizwan Hamid; Stephen J Brandt
Journal:  Mol Oncol       Date:  2009-07-29       Impact factor: 6.603

Review 9.  Monitoring PML-RARalpha in acute promyelocytic leukemia.

Authors:  Joseph G Jurcic
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

10.  Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture.

Authors:  Rachid Safi; Garrett G Muramoto; Alice B Salter; Sarah Meadows; Heather Himburg; Lauren Russell; Pamela Daher; Phuong Doan; Mark D Leibowitz; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Mol Endocrinol       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.